Search Results for: RedHill

Trials success for gastroenteritis treatment

Israeli biotech Redhill has announced that the Phase 3 trial of its BEKINDA treatment for acute gastroenteritis and gastritis, on 321 patients in 21 US clinical sites, met its targets for efficacy and safety. There are some 179 million cases … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Two kibbutzniks founded a NASDAQ biotech

Israelis Dror Ben-Asher and Ori Shilo founded the biotech RedHill BioPharma – named after the earth-red hill that the kibbutz overlooked. Now their company is successfully trialing treatments to cure Crohn’s disease, Helicobacter pylori, stomach cancer and much more. http://www.timesofisrael.com/kibbutz-duo-turned-entrepreneurs-on-quest-to-whip-gut-bugs/

Posted in Israel's Medical Achievements | Leave a comment

Successful trials for treatment of gastric infections

Israel’s Redhill Biopharma announced positive top-line results from its Phase III study with RHB-105 for treating Helicobacter pylori (H. pylori) infections. RHB-105 achieved 89.4% efficacy in eradicating H. pylori with no serious adverse events or unexpected safety issues. http://www.redhillbio.com/RedHill/Templates/showpage.asp?DBID=1&LNGID=1&TMID=178&FID=1358&PID=0&IID=1947

Posted in Israel's Medical Achievements | Leave a comment

New pancreatic cancer treatment is now Israeli

Normally, foreign investors acquire Israeli biotechs that develop cancer treatments. But here, Israel’s Redhill Biopharma has bought pancreatic cancer treatment RP101 from Germany’s RESprotect GmbH. RP101 has passed Phase II trials and has vital orphan status. http://ir.redhillbio.com/releasedetail.cfm?ReleaseID=866033

Posted in Israel's Medical Achievements | Leave a comment

Positive results in Type 1 diabetes treatment study

Israel’s Redhill Biopharma announced preliminary positive data from a pre-clinical study with RHB-104 for the treatment of Type 1 diabetes. Trials of RHB-104 for treating Crohn’s disease and Multiple Sclerosis are on going and are planned for Rheumatoid Arthritis. http://online.wsj.com/article/PR-CO-20140626-905884.html

Posted in Israel's Medical Achievements | Leave a comment

Nausea drug success

Israel’s Redhill Biopharma announced success in Phase III trials of RHB-102 – a once-a-day pill for the prevention of nausea in cancer patients. Redhill now plans to apply to the US Food and Drug Administration for a pre-New Drug Application … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Pill to vanquish nausea after chemo

(Thanks to Israel21c) Israel’s RedHill Biopharma is to perform advanced clinical trials of a once-a-day drug, code-named RHB-102, to prevent nausea and vomiting – often a side effect of chemotherapy and radiation therapy for cancer. Current medication for this purpose … Continue reading

Posted in Israel's Medical Achievements | Leave a comment